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Besidestheirevidentimportanceinhostdefense,macrophageshavebeenshowntoplayadetrimentalroleindiﬀerentpathological
conditions, including chronic inﬂammation, atherosclerosis, and cancer. Regardless of the exact situation, macrophage activation
and migration are intimately connected to extracellular matrix degradation. This process is accomplished by multiple proteolytic
enzymes, including serine proteases and members of the matrix metalloproteinase family. In this study, we have utilized qPCR
arrays to simultaneously analyze the temporal expression pattern of a range of genes involved in extracellular matrix metabolism
in the mouse derived-macrophage cell line RAW 264.7 following stimulation with LPS. Our results revealed that LPS induces the
expression of matrix metalloproteinases while at the same time decreased the expression of matrix metalloproteinase inhibitors.
The opposite scenario was found for the genes encoding serine proteases, which were downregulated while their inhibitors were
upregulated. In addition, intergenic comparison of the expression levels of related proteases revealed large diﬀerences in their
basal expression level. These data highlight the complexity of the gene expression regulation implicated in macrophage-dependent
matrixdegradation and furthermoreemphasize thevalue of qPCR arraytechniques for the investigation of the complex regulation
of the matrix degradome.
1.Introduction
Macrophages are involved in many aspects of immunity. In
additiontoclearingapoptoticcellsandcellulardebrisfollow-
ing infection and tissue damage, they also play an important
regulatory role by modulating immune responses through
the secretion of pro- or anti-inﬂammatory cytokines [1].
Though macrophages clearly are important for a functional
immune system, they have also been shown to exacerbate
pathological conditions involving chronic inﬂammatory
reactions, including atherosclerosis and cancer [2–4].
The participation of monocytes/macrophages in an
immune response depends on their ability to migrate
through the tissue to the inﬂammatory site, and it has
been thoroughly documented that this process involves
degradation of the extracellular matrix (ECM) [5–7]. For
this purpose, macrophages may orchestrate the recruit-
ment/activation of cells capable of secreting the necessitated
proteases or they may produce the proteases and protease-
activators themselves [8].
Seemingly, the serine protease, plasmin, and members of
the plasminogen- (Plg) activation system (PA-system) are of
particular importance for monocyte/macrophage migration,
asmicedeﬁcientingenesencodingeitherPlg-oraPA-system
component display a severe impediment in macrophage
recruitment [5, 9]. Though macrophages do not produce
Plg themselves, they express urokinase-Plg activator (uPA)
and its cell surface receptor, uPA-receptor (uPAR), thus
facilitatingalocalizedconversionofPlgtoactiveplasmin[5].
Besides the PA-system, macrophage migration has also been
shown to depend on individual matrix metalloproteinases
(MMPs), such as MMP9 and MMP12 [9, 10]. The protease2 Mediators of Inﬂammation
substrates, which need to be degraded prior to an adequate
recruitment of macrophages, have yet to be identiﬁed. This
task is not only hampered by the complexity of the ECM, but
also by the fact that global datasets describing the temporal
expression of the genes involved in ECM metabolism are
lacking.
In the presented study, we have determined the temporal
changes in the expression of genes encoding key proteases
and ECM components in macrophages following activation
by LPS using the StellARray qPCR array system, which
allows for the simultaneous quantiﬁcation of up to 95
gene transcripts. The qPCR data were analyzed using both
a recently published Global Pattern Recognition (GPR)
algorithm [11] and a standard fold-change analysis. In
addition, the mRNA level of all analyzed genes was directly
compared using a novel method in which DNA was used as a
global calibrator for all genes. Utilizing these methods, we
were able to identify a pronounced diﬀerence in the basal
RNA expression level of related proteases (e.g., a 16-fold
higherbasalexpressionlevelwasobservedforMMP13versus
MMP8 and for MMP9 versus MMP2). Furthermore, the Plg
activators and their inhibitors were shown to be inversely
regulated by LPS stimulation, which decreased the RNA
expression of the activators while the RNA expression of
the inhibitors was increased. A similar but opposite pattern
was found for MMPs where RNA expression was increased
for MMPs, whereas it was decreased for the MMP inhibitor
Tissue Inhibitor of MMPs- (Timp-) 2. Thus, stimulation
with a single compound induces inverse regulation of genes
with opposing functions.
2.MaterialsandMethods
2.1. RAW 264.7 Cells. The mouse-derived macrophage cell
line RAW 264.7 was propagated in culture medium deﬁned
as DMEM, containing 10% FCS and 1% Penicillin-
Streptomycin (Sigma-Aldrich, Brøndby, Denmark). Exper-
imental cell cultures were set up in 6-well culture plates
by seeding 5 × 105 c e l l si n4 m Lc u l t u r em e d i u mi ne a c h
well. The following day, the culture medium was exchanged
with serum-free DMEM. After 4 hours, vehicle (PBS) or
LPS (Sigma-Aldrich, Brøndby, Denmark) was added to
appropriate cultures to a ﬁnal concentration of 100ng/mL.
After 0, 2, 6, and 18 hours of vehicle or LPS stimulation,
the RAW 264.7 cultures were harvested by removing the
supernatant and lysing the cells using the NucleoSpin RNAII
kit for RNA puriﬁcation (Macherey-Nagel, Germany). The
lysates were stored at −80◦C.
2.2. RNA Puriﬁcation and Reverse Transcription. RNA from
RAW 264.7 cell cultures was puriﬁed using the NucleoSpin
RNAII kit (Macherey-Nagel, D¨ uren, Germany). During the
puriﬁcation procedure, samples were treated with the DNase
included in the kit according to manufactures instruction.
The RNA concentration of the ﬁnal eluate was determined
using a NanoDrop1000 (Thermo Scientiﬁc, Copenhagen,
Denmark).
Reverse transcription was performed using the Super-
Script II RT-PCR system (Invitrogen, Nærum, Denmark)
with random primers (Roche Applied Science, Hvidovre,
Denmark) and dNTPs (Invitrogen, Nærum, Denmark).
cDNA was transcribed using 1μgR N Ai nat o t a lr e a c t i o n
volume of 20μL.
2.3. qPCR Array Analysis. The custom designed StellAR-
ray qPCR arrays (Lonza, Basel, Switzerland) were utilized
according to the manufactures instruction. Brieﬂy, 2.1mL
qPCR master mix was prepared using 1050μL 2X SYBR
Premix Ex Taq (TaKaRa, Shiga, Japan), 1046μL water and
4μL of the above-described cDNA solution. 20μLw a sa d d e d
toeachwelloftheStellARray96wellplate(oneplateforeach
sample). In addition, three samples of mouse genomic DNA
were analyzed on similar plates using a ﬁnal concentration of
0.2ng/μL DNA (Zyagen, California, USA). A LightCycler480
(Roche Applied Science, Hvidovre, Denmark) was used
with the following thermal proﬁle: 5min at 50◦C, 30sec at
95◦C, 40X (30sec at 95◦C, 1min at 60◦C). Melting curve
analysis was performed to test the speciﬁcity of the primer
pairs. The Cp’s were obtained using the Second Derivative
Maximum Method using the LightCycler480 software. The
plate setup, listing the analyzed genes, is presented in
supplementary material Table S1 available online at doi:
10.1155/2012/157894.
To enable direct comparison of RNA levels from diﬀerent
genes, a genomic DNA sample was used as calibrator and
the data was further normalized using a GeNorm-derived
normalization factor based on Ywhaz, Gapdh, and Tbp [12].
Importantly, when calculating fold changes of individual
genes using these relative RNA values, the results are equal to
anormaldeltadeltaCpcalculationsincetheDNAinthiscase
only functions as a calibrator sample and consequently does
notinﬂuencethefoldchangesobservedbetweentwosamples
[13].Furthermore,theuseofDNAasanintergeniccalibrator
requires that the compared genes are equally represented in
the genome. In the current set of investigated genes a BLAST
search of the ampliﬁed regions have shown that only the
reference genes RN18s, Gapdh, and Ywhaz were duplicated
thus disqualifying these for normalization to DNA. Finally,
theuseofDNAasacalibratorisevidentlyonlypossiblewhen
the primer pairs are not intron spanning:
Relative Copy Number
2−(Cptarget−CpDNA)
NF
×C,( 1 )
whereNFdesignatesaGeNormderivednormalizationfactor
based on Ywhaz, Gapdh and Tbp, and where Cp designates
a threshold values derived using the Second Derivative
Method, and C is an arbitrary constant dependent on the
DNA concentration. In this study C = 1000.
Besides a standard delta delta Cp-based fold change
analysis, the data were analyzed using the GPR algorithm
software supplied by the distributor of the StellARray kits
(Lonza, Basel, Switzerland). Shortly, the GPR algorithm
ﬁrst calculates delta Cp values for each gene of interest in
comparison with all other analyzed genes (normalizers). For
each gene-normalizer combination, the delta Cp values forMediators of Inﬂammation 3
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Figure 1: LPS induced RNA expression changes can be determined by StellARray qPCR arrays. RAW 264.7 cell cultures were stimulated
with 100 ng/mL LPS or vehicle for 0, 2, 6, and 18 hours, at which time point RNA was harvested for sequential gene expression analysis.
LPS stimulation led to a change in gene expression levels up to 512 fold (Il-6). This eﬀect was already evident after two hours and was
sustained for at least 18 hours. Pronounced diﬀerences in the basal level of expression (0 hours) were observed between genes (e.g., TGFβ1
and TGFβ2). Data were analyzed by a two-tailed Mann-Whitney test. ∗P<0.05 between LPS and vehicle-stimulated cultures. n = 4f o ra l l
groups.
the experimental and control group are compared using a
standard t-test. For every gene, a “hit” is recorded for each
obtained P-value less than 0.05. Next, all genes are given a
score based on the number of hits and ranked accordingly.
Finally, a bootstrap analysis is used to convert the individual
scores to P-values [11].
In addition to the GPR P-values, the software also
calculates fold changes in gene expression based on normal-
ization to either 18sRNA (RN18s fold change value) or by
normalization to ten genes selected by the software using an
unpublished algorithm (GPR fold change value).
3. Results
3.1. The Eﬀect of LPS on Gene Expression in Macrophages Is
Reliably Recapitulated by Array Analysis. Cultures of RAW
264.7 cells were treated with 100ng/mL LPS or vehicle and
harvested after 2, 6, or 18 hours. The mRNA expression
levels of 95 genes were analyzed by StellARray qPCR array. A
sampleofgenomicDNAcontainingallofthegenesencoding
the assayed transcripts was used as a calibrator and Tbp,
Ywhaz, and Gapdh transcripts were further used to generate
a GeNorm-based normalization factor to correct for inter-
assay variations. The M values for Tbp, Ywhaz, and Gapdh
were between 0.184 and 0.265 indicating that the three genes
were suitable as reference genes [12] .T h er e l a t i v ee x p r e s s i o n
levels for all analyzed genes are presented in Table S2.
The ability of the precoated qPCR arrays to generate
trustworthy Cp values was assessed by comparing expression
changes for a number of genes (Mmp9, Mmp12, Mmp13,
Gapdh, Tbp) using the same cDNA for both the arrays and
for conventional single gene expression analysis using SYBR
green-based qPCR. No diﬀerences were found in the data
derived from the two diﬀerent methods, thus showing that
the arrays delivered trustworthy results of a high standard
(data not shown).
To conﬁrm that the LPS stimulation of RAW 264.7
cells had led to the expected inﬂammatory response, we
scrutinized the mRNA expression of classical inﬂammatory
cytokines. The data showed that upon LPS stimulation,
RAW 264.7 cells responded by increasing the expression of
interleukin (Il)-1β, Il-6, Il-10, TNF-α,a n dT G F β2, while
TGFβ1 expression was unaﬀected and TGFβ3 expression
decreased over time. It was noted that the basal expression
levelofthecytokines variedconsiderablyat0hours,atwhich
pointtheexpressionofTNF-αandTGFβ1wassome256-fold
higher than that of Il-1β, Il-6, and Il-10. In comparison with
LPS treatment, the mRNA expression level of the cytokines
varied only to a minor degree over time following vehicle
treatment (Figure 1).
3.2. LPS Increases the RNA Expression of MMPs and Decreases
the Expression of MMP Inhibitors. A comparison of the re-
lative basal RNA expression levels of MMPs in untreated4 Mediators of Inﬂammation
RAW 264.7 cultures revealed that the expression levels
of MMP genes varied considerably even within the same
classes of MMPs. For instance, the collagenases, MMP8 and
MMP13, showed a 16 fold diﬀerence in expression levels,
and the gelatinases, MMP2 and MMP9, showed a 32-fold
diﬀerence in expression levels (Figure 2). A comparison of
LPS and vehicle-stimulated RAW 264.7 cultures showed
that LPS treatment led to a general increase in MMP RNA
expression with few exceptions (Figure 2). When comparing
vehicle-treated cultures with cultures harvested at 0 hours,
it was clear that either serum deprivation or the time span
lastingupto18hourshadaneﬀectonMMPRNAexpression
levels, which in most cases were decreased. However, this fact
had no evident eﬀect on the ability of LPS to increase the
MMP RNA level.
As actual MMP activity is strictly regulated by TIMPs,
we chose also to investigate the eﬀect of LPS stimulation
on TIMP RNA expression using the StellARray qPCR array
system. We found that the general increase in MMP RNA
expression following LPS treatment was accompanied by
a decrease in the RNA expression of the MMP inhibitor
TIMP2. TIMP1 RNA expression, however, remained fairly
constant over time, though a small decrease following LPS
treatment was observed at 6 hours post-treatment compared
to vehicle-stimulated controls. Furthermore, the Timp1 gene
was expressed at levels some 128-fold lower than Timp2
(Figure 3). Timp3 was not found to be expressed in neither
LPS nor vehicle-stimulated cultures. In contrast, Timp4 was
expressed at low levels but not regulated by LPS treatment
(data not shown).
3.3. Decreased RNA Expression of Plg-Activators Is Accompa-
nied by an Increased Expression of Plg-Activator Inhibitors.
Following LPS treatment, RAW 264.7 cells downregulated
their expression of the two Plg-activators Plat and Plau (tPA
and uPA) by two and four folds, respectively. However, this
eﬀect was ﬁrst detectable at 6 hours following treatment.
Further analyses of the relative RNA expression levels
between Plat and Plau, revealed that Plau was expressed
at levels that were approximately 512 fold higher than Plat
(Figure 4(a)).
While the RNA expression of the Plg-activators was
decreased by LPS treatment, the opposite was true for the
inhibitors of tPA and uPA, PAI-1, and PAI-2 (Serpine1 and
Serpinb2). Their expression was increased by up to 32 folds.
This was evident already at two hours following treatment.
In addition, the direct comparison of Serpine1 and Serpinb2
showed that the relative expression level of Serpine1 was 8
fold higher than that of Serpinb2 (Figure 4(b)).
3.4. Genes Encoding Extracellular Matrix Proteins Are Not
Widely Expressed by RAW 264.7 Cells. Extensive analysis
of the expression of genes encoding ECM components
revealed that this group of genes was expressed at a very low
level with few exceptions, such as Fn1, Lama5, and especially
Lamc1, which had a basal expression level that were approx-
imately 100 fold higher than that of the other detectable
gene transcripts. Among the gene transcripts that could be
d e t e c t e d ,o n l yV t n ,L a m a 2 ,a n dL a m b 3s e e m e dt ob ea ﬀected
by LPS treatment, in that they were increased by two to 16
fold (Figure S1).
3.5. Other Protease Systems Expressed by RAW 264.7 Cells. In
addition to the MMPs and the PA-system, the RNA expres-
sion of a number of proteases not belonging to these groups
were investigated. We found that the Tmprss6, Prss8, and
St14 genes, encoding transmembrane protease serine 6,
Prostasin, and Matriptase, respectively, were expressed by
RAW 264.7 cells. In addition, St14 RNA expression was
found to be downregulated two fold by LPS treatment
(Table S2).
3.6. Global Pattern Recognition Analysis. The GPR algorithm
published by Akilesh et al. (2003) is made available by Lonza
(Lonza, Switzerland) to facilitate the analysis of data derived
from their qPCR array system, StellARray [11]. Without
the use of prior-deﬁned reference genes, the GPR algorithm
analyzes for diﬀerential gene expression patterns between
two groups, generating a P-value based on the consistency
of the biological replicates. We analyzed the RAW 264.7
expression data using the GPR algorithm on the following
datasets: LPS versus vehicle after 2, 6, and 18 hours. The GPR
algorithm identiﬁed signiﬁcant changes in the expression
pattern of many of the genes that were also found to be
up- or downregulated as determined by classical fold change
analysis. However, a number of genes with a seemingly
constantexpressionlevel,accordingtobothGPRfoldchange
analysis and classical fold change analysis, also received low
GPR P-values (e.g., TGFβ1) (Table S3). These data illustrate
the diﬀerent meanings of GPR derived P-values and fold-
changederivedP-valuesandemphasizethatthereisnodirect
link between changes in gene expression levels and GPR P-
values. Thus, GPR P-values cannot be applied to fold change
data for the individual gene transcripts.
4. Discussion
In the present study, we successfully implemented a novel
method for intergenic comparison of RNA transcript levels
using genomic DNA encoding all assayed transcripts as
a calibrator. Using this method, we revealed considerable
diﬀerences in the relative levels of gene transcripts between
various protease systems and ECM components. Further-
more, we found that a group of genes involved in ECM
metabolism was inversely regulated in macrophages follow-
ing stimulation with a single compound, LPS. Interestingly,
this inverse regulation could function to induce a synergistic
eﬀect on ECM turnover or simply reﬂect the complex
and tight regulation of extracellular proteolysis, as it was
mainly genes encoding proteases or protease activators and
their inhibitors that were counterregulated. The observed
alterations in gene expression levels over time in vehicle-
stimulated cultures likely reﬂect serum deprivation or a time
dependent change in the expression pattern. In any case, it
did not block the proinﬂammatory eﬀects of LPS treatment.
Finally, we evaluated and compared a novel GPR analysisMediators of Inﬂammation 5
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Figure 2: Widespread increase in the MMP gene expression level following LPS treatment. The RNA expression of MMPs following LPS
treatment of macrophage cultures was generally increased compared to vehicle stimulated cultures. The basal expression level of MMPs (0
hours) varied considerably and the most abundantly expressed MMP (MMP12) had a 20,000-fold higher expression level than the lowest
detectable MMP (MMP3). Data were analyzed by a two-tailed Mann-Whitney test. ∗P<0.05 between LPS and vehicle stimulated cultures.
n = 4 for all groups.6 Mediators of Inﬂammation
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Figure 3: The RNA expression of genes encoding MMP inhibitors
are downregulated in activated macrophages. Whereas LPS led to a
general increase in MMP gene expression, the genes encoding the
MMP inhibitors TIMP1 and TIMP2 were downregulated in LPS-
stimulated cultures compared to vehicle-treated control cultures.
The diﬀerence in the basal RNA expression levels (0 hours) between
Timp1 and Timp2 diﬀered by 128 folds. Data were analyzed by a
two-tailed Mann-Whitney test. ∗P<0.05 between LPS and vehicle-
stimulated cultures. n = 4 for all groups.
tool for assessing transcriptional changes in array data with a
classical delta delta Cp-based fold change analysis.
To gain an in depth knowledge of protease gene tran-
scription in RAW 264.7 cells before and after LPS stimu-
lation, we determined the relative expression levels using
a DNA calibrator. Alternatively, absolute qPCR could have
beenappliedforthedirectcomparisonoftranscriptnumbers
of individual genes. However, this method relies on standard
curves with known copy numbers generated using in vitro
transcribed sense RNA, plasmids or oligonuclotides. This
input material needs prior normalization to weight, total
RNA, size or cell number, which may vary independently
of target gene regulation and thereby increase the risk of
skewing data [14].
T h eu s eo fg e n o m i cD N Aa sag l o b a lc a l i b r a t o rf o r
all genes requires that all genes are equally represented in
the genome, and if not (such as genes located on the sex
chromosomes or duplicated genes), a correction for the
copy number must be performed. In the current study,
only Timp1 was found to be located on a sex chromosome
and consequently one cycle was subtracted from the DNA
calibrator Cp value for this gene. Furthermore, only the
reference genes included (Ywhaz, Gapdh, Rn18s) had veri-
ﬁed gene duplications, whereas none of the target sequences
showed any potential of being represented more than once
in the genome. In addition, melting curve analysis showed
that the used primers for each gene only gave rise to a
single product. Thus, using a DNA sample as a calibrator
we obtained an equal arbitrary set point for RNA transcript
levels. This method provides a simple way for intergenic
RNA transcript comparisons, though extra caution for DNA
contaminationshouldbetaken.Despitethepotentialpitfalls,
the intergenic diﬀerences we found using this method are
corroborated by other studies, which have performed abso-
lute RNA quantiﬁcation analysis of MMP related genes in
unstimulated human monocytes [15]. In this context, we
found MMP9, MMP10, MMP19, and TIMP2 to be highly
expressed in comparison to MMP2, MMP3, MMP21, and
TIMP3, which mimics the data presented by Reel et al., 2011
[15]. However, it should be noted that diﬀerences were also
observedwhichlikelycouldbeaddressedtodiﬀerencesinthe
model systems.
It is well established that macrophages, upon activa-
tion, change the gene expression levels of many of the
components involved in ECM degradation [16]. The eﬀect
of LPS on the RAW 264.7 macrophage transcriptome has
previously been investigated using DNA chip technology
[17]. In comparison to this whole genome chip analysis,
we identiﬁed an additional 20 protease/ECM related genes
with an altered expression pattern [17]. This possibly reﬂects
the high sensitivity of qPCR arrays or varying levels of
macrophage activation between the two studies. Both studies
identiﬁed PAI-1 and PAI-2 as being highly upregulated on
the RNA level, however, Gao et al. found TIMP-1 to be
upregulated whereas the current analysis only showed a
minor eﬀect of LPS treatment on TIMP-1 RNA expression
[17]. In addition, our expression data is corroborated by
studies of LPS-treated human-derived monocytes, in which
increased levels of MMP9, MMP10, MMP14, and decreased
levels of TIMP-2 were reported [15]. LPS treatment of
isolated tissues, containing a mixed cell population including
macrophages, also leads to increased MMP and decreased
TIMP2 RNA expression levels [18]. Interestingly, the latter
study also reported altered expression of genes that were not
aﬀected by LPS treatment of RAW 264.7 cells in the current
study. This may be due to direct or indirect induction of
gene transcription in other cell types (e.g., ﬁbroblasts) or
reﬂect the importance of the microenvironment in terms of
regulating gene expression in macrophages.
The protein expression of extracellular proteases and
their inhibitors is regulated at several levels, including the
induction of transcriptional activity and by the modulation
ofmRNAturnover[19].However,changesinthemRNAlev-
els of extracellular proteases does not directly reﬂect changes
in the extracellular proteolytical environment as many extra-
cellular proteases and their activators are secreted as inactive
proenzymes, which themselves need to be proteolytically
activated. In addition, in an in vitro system such as the
one used in the current report, the protease activators
needed to activate the proteases produced by LPS-stimulated
RAW 264.7 cells may be entirely absent. Despite these facts,
in vivo studies have shown that for some proteases, in
deﬁned tissues, mRNA and protein expression levels and
even proteolytical activity correlates [20, 21]. However, in
other situations, such as the secretion of preformed MMP9Mediators of Inﬂammation 7
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Figure 4: The RNA encoding plasminogen activators are downregulated while their inhibitors are upregulated. (a) Six hours following LPS
stimulation, RAW 264.7 cells downregulated the expression of genes encoding the two main Plg activators, tPA and uPA. (b) In contrast to
the decreased expression of Plat and Plau, the expression of the two tPA and uPA inhibitors, Pai-1 and Pai-2, was increased by up to 16 folds.
Data were analyzed by a two-tailed Mann-Whitney test. ∗P<0.05 between LPS and vehicle-stimulated cultures. n = 4 for all groups.
by neutrophils following a proinﬂammatory stimulus, there
is no direct link between protein synthesis and secretion
[22, 23]. These facts emphasize that expression arrays of
ECM remodulation genes do not in all cases reﬂect the actual
proteolytical environment. However, highly sensitive qPCR
arrays limited to proteases and ECM components, as the
one presented in the current report, are a valuable tool for
investigating the signaling pathways leading from extracellu-
larstimulitogeneexpressionontheRNAlevel.Thesignaling
pathway from LPS stimulation of macrophages/monocytes
to MMP gene transcription is highly complex but has
been shown to depend on MAP kinases in vitro, while
in vivo, a pathway involving cyclooxygenase activation and
prostaglandin synthesis followed by cAMP production also
is involved [15, 24]. In the current study, we found that
macrophage activation by LPS led to a general increase in
MMPRNAexpression levels thoughtoa varying extent. This
likely reﬂects diﬀerences in the promoter sequences of MMP
genes [25] or in the pace at which the individual mRNAs are
degraded. The surprising observation that LPS had opposite
eﬀects on RNA expression levels of genes encoding proteases
and inhibitors belonging to the same protease system (e.g.,
in the PA-system, uPA was downregulated and PAI-1 and
PAI-2 were upregulated) could also reﬂect variations in the
promoter sequences or in mRNA degradation, which would
serve to enhance the tight regulation of Plg activation.
The fact that extracellular proteases have overlapping
functions emphasizes the value of the simultaneous inves-
tigation of multiple proteases as performed in the present
study. This may be exempliﬁed by the current array data
showing that macrophages express both of the two Plg
activators tPA and uPA, which is corroborated by previous
reports [26, 27]. In addition, our array data reveal that
macrophages express tPA at a 4000 fold lower level than that
of uPA on the RNA level. High-resolution arrays as the one
presentedmayalsoprovevaluableincomplexdiseasemodels
where an interaction or a direct functional overlap between
diﬀerent proteases is presumed to play a role [28, 29].
The StellARray qPCR platform proved to be an eﬃcient
method for obtaining expression data and the GPR P-value,
based on the GPR algorithm, is an interesting approach
for qPCR array analysis as there is no need for predeﬁned
reference genes [11]. However, as the GPR algorithm is a
pattern-based analysis software, which is generally visualized
by comparing the relative “position” of each gene in one
group to its “position” in the other group (Figure 5), it
should be kept in mind that the GPR P-value does not pro-
vide any information regarding whether the expression level8 Mediators of Inﬂammation
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Figure 5: Schematic diagram of expected P-values based on fold
change and GPR analyses. The left side of the diagram shows a
hypothetic GPR analysis of two groups (1 & 2) with a general and
equal increase in gene expression levels in group 2 compared to
group 1. In this case it is the single gene “E” that does not change
its expression level that receives the lowest P-values. This result is
based on the GPR algorithm where all genes are normalized to each
other. The right side of the diagram shows the same scenario but
analyzedusingaclassicalfoldchangestatisticalanalysis(e.g.,Mann-
Whitney test). As depicted, these two methods, although both
mathematically consistent, give rise to diﬀerent results. ∗ indicates
a statistical signiﬁcant change.
of the individual gene has been altered. The presented data
corroborate this notion as GPR P-values in some cases were
below 0.05 for genes with minute and insigniﬁcant changes
inexpressionlevelsasdeterminedbyaclassicaldeltadeltaCp
analysis.AstheGPRalgorithmdoesnotprovideinformation
regardingthesigniﬁcanceofup-downregulation,thebiologi-
calinterpretationofGPRP-valuesisdiﬃcultandcareshould
be taken not to confuse GPR P-values for P-values based on
actual fold change analyses. Thus, it should be stressed that
the presented GPR fold change values and the RN18s-based
fold change values determined by the GPR software cannot
be combined with the GPR P-values. In relation to the GPR
fold change values, we found that they were highly similar to
the values obtained using a GeNorm-derived normalization
factor based on Ywhaz, Gapdh, and Tbp. In comparison, the
Rn18s-based fold change values were a bit skewed compared
tobothofthesevaluesemphasizingthatsinglereferencegene
normalization is jeopardized by potential regulation of the
reference gene [30].
In conclusion, the presented data and analyses show how
activated macrophages respond to LPS by altering the bal-
anceofgeneexpressionlevelsbetweenextracellularproteases
and their inhibitors. Furthermore, by taking advantage of
a genomic DNA calibrator, we were able to show that the
relative gene expression levels between related genes diﬀer
with up to 500 folds. The presented approach may not
only serve as a highly sensitive expression screening but also
be used to directly investigate signaling pathways and gene
expression regulation on a higher level.
Abbreviations
ECM: Extracellular matrix
MMP: Matrix metalloproteinase
GPR: Global Pattern Recognition
(PA)-system: plasminogen activation system.
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